Indeed, Sehirli et al. used spironolactone at 80 mg.kg-1 for 7 days in Sprague-Dawley rats with acute TNBS-induced colitis and they observed that spironolactone reduced inflammation with a lower NF-κB activity and colon MPO31. The gene discussed is NFKB1; the disease is colitis.